8-substituted-6, 7, 8, 9-tetrahydropyrimido(1,2-a) pyrimidin4-one derivatives

Details for Australian Patent Application No. 2004222596 (hide)

Owner Mitsubishi Pharma Corporation Sanofi-Aventis

Inventors Slowinski, Franck; Saady, Mourad; Yaiche, Philippe; Lochead, Alistair

Agent Davies Collison Cave

Pub. Number AU-B-2004222596

PCT Pub. Number WO2004/082577

Priority 03290727.1 21.03.03 EP

Filing date 19 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 28 August 2008

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/082577 Priority application(s): WO2004/082577

28 August 2008 Application Accepted

  Published as AU-B-2004222596

8 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222605-Consignment inventory management and reconciliation system

2004222587-Dose dial and drive mechanism suitable for use in drug delivery devices